​​Though not ASRI-sponsored missions, the ARTIS Mission Series – conceived and developed by a private Dutch corporation, SpaceBorn United Inc. (SBU) – will focus on application of clinical IVF biotechnology in microgravity environments, employing Assisted Reproductive Technology in Space (ARTIS).  Earlier ARTIS missions will attempt in-orbit IVF fertilization and development of mouse embryos, with follow-on experiments using human embryos to validate the possibility of IVF-driven conception in space. You can learn more about the ARTIS missions here.

​

Disclaimer:  ASRI is not an official partner of SpaceBorn United Inc. and this information does not constitute endorsement of or intellectual property association with SBU or their ARTIS missions/plans -- it is presented here and against the SHARP Missions overview purely for informational and timeline context purposes, and is based on publicly available information listed on SBU's official website. Any academic information specific to ARTIS is accredited to SBU, and should be considered separate and external from ASRI, the SHARP Mission Roadmap, and SHARP's associated mission series.

​

Projected Missions:

​​

ARTIS - 1  (2025)

ARTIS - 2  (2026)

ARTIS - 3  (2027)

ARTIS - 4  (2028)

ARTIS - 5  (2029)​​

ARTIS - 6  (2030)

ARTIS - 7  (2032)​

​